Erratum for the Research Article: “The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study” by P. Kiessling, R. Lledo-Garcia, S. Watanabe, G. Langdon, D. Tran, M. Bari, L. Christodoulou, E. Jones, G. Price, B. Smith, F. Brennan, I. White, S. Jolles

See allHide authors and affiliations

Science Translational Medicine  06 Dec 2017:
Vol. 9, Issue 419, eaar6448
DOI: 10.1126/scitranslmed.aar6448

Article Information

vol. 9 no. 419

Print ISSN: 
Online ISSN: 
    Other Contributors: 
    • American Association for the Advancement of Science

    Author Information


    Article usage

    Article usage: December 2017 to October 2018

    Dec 2017029000
    Jan 201801240
    Feb 20180770
    Mar 20180620
    Apr 20180670
    May 201801010
    Jun 20180600
    Jul 20180500
    Aug 201801040
    Sep 20180640
    Oct 20180620

    Navigate This Article